OpenEvidence dropped one of its three lawsuits over allegedly stolen medical-AI trade secrets after Pathway Medical Inc. was bought by Doximity Inc., a defendant in one of its other cases.
The medical tech company cited the acquisition announced in August in its Thursday notice of voluntary dismissal without prejudice in the US District Court for the District of Massachusetts. It had sued Pathway in February, months before filing June lawsuits against Doximity and Veracity-Health Inc. featuring similar allegations.
OpenEvidence plans to still press allegations from its complaint against Pathway, “but it is more efficient to pursue them in the suit ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.